Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-08-2007 | Original Article

Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with ¹³N-ammonia and PET

Authors: Thomas H. Schindler, Xiao-Li Zhang, John O. Prior, Jerson Cadenas, Magnus Dahlbom, James Sayre, Heinrich R. Schelbert

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2007

Abstract

Purpose

We investigated the intraobserver reproducibility of myocardial blood flow (MBF) measurements with PET at rest and during cold pressor test (CPT), and the interobserver agreement.

Methods

Twenty normal volunteers were studied. Using ¹³N-ammonia, MBF was measured at rest and during CPT and measurement was repeated in a 1-day session (short-term reproducibility; SR). After a follow-up of 2 weeks, MBF was measured again at rest and during CPT and compared with the initial baseline measurement (long-term reproducibility; LR). In addition, adenosine-induced hyperemic MBF increases were assessed.

Results

Assessment of the SR did not show a significant absolute difference in MBF at rest, MBF during CPT or the endothelium-related change in MBF from rest to CPT (ΔMBF) (0.09 ± 0.10, 0.11 ± 0.09, and 0.08 ± 0.05 ml/g/min; p = NS), and they were linearly correlated (r = 0.72, r = 0.76 and r = 0.84; p < 0.0001). Corresponding values for standard error of the estimate (SEE), as indicative for the range of MBF measurement error, were 0.14, 0.14, and 0.09 ml/g/min. The LR yielded relatively higher but non-significant absolute differences in the MBF at rest, MBF during CPT and ΔMBF (0.10 ± 0.10, 0.14 ± 0.10, and 0.19 ± 0.10 ml/g/min; p = NS), and paired MBFs significantly correlated (r = 0.75, r = 0.71, and r = 0.60; p < 0.001). Corresponding SEEs were 0.13, 0.15, and 0.16 ml/g/min. The interobserver analysis yielded a high correlation for MBF at rest, MBF during CPT, and hyperemic MBF (r = 0.96, SEE=0.04; r = 0.78, SEE=0.11; and r = 0.87, SEE=0.28; p < 0.0001, respectively), and also a good interobserver correlation for ΔMBF (r = 0.62, SEE=0.09; p < 0.003).

Conclusion

Short- and long-term MBF responses to CPT, as an index for endothelium-related coronary vasomotion, can be measured reproducibly with ¹³N-ammonia PET. In addition, the high interobserver reproducibility for repeat analysis of MBF values suggests the measurements to be largely operator independent.

Campisi R, Nathan L, Pampaloni MH, Schoder H, Sayre JW, Chaudurie G, et al. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 2002;105:425–30.CrossRefPubMed

Prior JO, Quinones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005;111:2291–8.CrossRefPubMed

Schindler TH, Nitzsche EU, Olschewski M, Brink I, Mix M, Prior J, et al. PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. J Nucl Med 2004;45:419–28.PubMed

Wyss CA, Koepfli P, Namdar M, Siegrist PT, Luscher TF, Camici PG, et al. Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia. Eur J Nucl Med Mol Imaging 2005;32:84–91.CrossRefPubMed

Pirich C, Leber A, Knez A, Bengel FM, Nekolla SG, Haberl R, et al. Relation of coronary vasoreactivity and coronary calcification in asymptomatic subjects with a family history of premature coronary artery disease. Eur J Nucl Med Mol Imaging 2004;31:663–70.CrossRefPubMed

Momose M, Abletshauser C, Neverve J, Nekolla SG, Schnell O, Standl E, et al. Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus. Eur J Nucl Med Mol Imaging 2002;29:1675–9.CrossRefPubMed

Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med 2005;46:75–88.PubMed

Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang XL, et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 2006;47:1188–95.CrossRefPubMed

Schindler TH, Nitzsche EU, Olschewski M, Magosaki N, Mix M, Prior JA, et al. Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors. Circulation 2004;110:1069–75.CrossRefPubMed

10.

Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363–8.CrossRefPubMed

11.

Schindler TH, Nitzsche EU, Schelbert HR, Olschewski M, Sayre JG, Mix M, et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol 2005;45:1505–12.CrossRefPubMed

12.

Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027–35.CrossRefPubMed

13.

Britten MB, Zeiher AM, Schachinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 2004;15:259–64.CrossRefPubMed

14.

Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984–92.PubMed

15.

Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989;14:1181–90.CrossRefPubMed

16.

Quinones MJ, Hernandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenez X, De La Rosa R, et al. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med 2004;140:700–8.PubMed

17.

Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Luscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000;102:1233–8.PubMed

18.

Wielepp P, Baller D, Gleichmann U, Pulawski E, Horstkotte D, Burchert W. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease. Eur J Nucl Med Mol Imaging 2005; 32 12:1371–7.CrossRefPubMed

19.

Hattori N, Schnell O, Bengel FM, Rihl J, Nekolla SG, Drzezga AE, et al. Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus. Eur J Nucl Med Mol Imaging 2002;29:891–8.CrossRefPubMed

20.

Tsukamoto T, Morita K, Naya M, Katoh C, Inubushi M, Kuge Y, et al. Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2006;33:1150–60.CrossRefPubMed

21.

Schindler TH, Nitzsche EU, Munzel T, Olschewski M, Brink I, Jeserich M, et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. J Am Coll Cardiol 2003;42:814–22.CrossRefPubMed

22.

Czernin J, Barnard RJ, Sun KT, Krivokapich J, Nitzsche E, Dorsey D, et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation 1995;92:197–204.PubMed

23.

Chan SY, Kobashigawa J, Stevenson LW, Brownfield E, Brunken RC, Schelbert HR. Myocardial blood flow at rest and during pharmacological vasodilation in cardiac transplants during and after successful treatment of rejection. Circulation 1994;90:204–12.PubMed

24.

Nagamachi S, Czernin J, Kim AS, Sun KT, Bottcher M, Phelps ME, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996;37:1626–31.PubMed

25.

Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi O, Camici PG. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with¹⁵O-labeled water and PET. J Nucl Med 1999;40:1848–56.PubMed

26.

Siegrist PT, Gaemperli O, Koepfli P, Schepis T, Namdar M, Valentina I, et al. Repeatability of cold pressor test-induced flow increase assessed with H₂ ¹⁵O and PET. J Nucl Med 2006;47:1420–6.PubMed

27.

Kuhle WG, Porenta G, Huang SC, Buxton D, Gambhir SS, Hansen H, et al. Quantification of regional myocardial blood flow using¹³N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 1992;86:1004–17.PubMed

28.

Porenta G, Kuhle W, Czernin J, Ratib O, Brunken RC, Phelps ME, et al. Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. J Nucl Med 1992;33:1628–36.PubMed

29.

Schindler TH, Facta AD, Prior JO, Campisi R, Inubushi M, Zhang XL, et al. PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction. Eur J Nucl Med Mol Imaging 2006;33:1140–9.CrossRefPubMed

30.

Weinberg IN, Huang SC, Hoffman EJ, Araujo L, Nienaber C, Grover-McKay M, et al. Validation of PET-acquired input functions for cardiac studies. J Nucl Med 1988;29:241–7.

31.

Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989;30:359–66.PubMed

32.

Schelbert HR, Phelps ME, Huang SC, MacDonald NS, Hansen H, Selin C, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259–72.PubMed

33.

Prior JO, Schindler TH, Facta AD, Hernandez-Pampaloni M, Campisi R, Dahlbom M, et al. Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans. Eur J Nucl Med Mol Imaging 2007;34:20–7.CrossRefPubMed

34.

Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10.PubMed

35.

Sawada S, Muzik O, Beanlands RS, Wolfe E, Hutchins GD, Schwaiger M. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography. J Nucl Cardiol 1995;2:413–22.CrossRefPubMed

36.

Kawano H, Motoyama T, Yasue H, Hirai N, Waly HM, Kugiyama K, et al. Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina. J Am Coll Cardiol 2002;40:266–70.CrossRefPubMed

37.

Schindler TH, Facta A, Prior J, Cadenas J, Hsueh W, Quinones M, et al. Improvement of coronary vascular dysfunction in type 2 diabetic patients with euglycemic control. Heart 2006 Aug 29; [Epub ahead of print].

38.

Bengel FM, Abletshauser C, Neverve J, Schnell O, Nekolla SG, Standl E, et al. Effects of nateglinide on myocardial microvascular reactivity in type 2 diabetes mellitus-a randomized study using positron emission tomography. Diabet Med 2005;22:158–63.CrossRefPubMed

39.

Wyss CA, Koepfli P, Mikolajczyk K, Burger C, von Schulthess GK, Kaufmann PA. Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. J Nucl Med 2003;44:146–54.PubMed

40.

Jagathesan R, Kaufmann PA, Rosen SD, Rimoldi OE, Turkeimer F, Foale R, et al. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. J Nucl Med 2005;46:212–9.PubMed

Title: Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with 13N-ammonia and PET
Authors: Thomas H. Schindler
Xiao-Li Zhang
John O. Prior
Jerson Cadenas
Magnus Dahlbom
James Sayre
Heinrich R. Schelbert
Publication date: 01-08-2007
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-007-0378-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with ¹³N-ammonia and PET

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2007

The “White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging”: a message from the EANM and ESR Presidents

The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation

DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours

EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases

Abdominal visceral fat accumulation is associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients

[18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer